Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study.
Kota TakumaAyako FuchigamiFumika ShigiyamaNaoki KumashiroTakahisa HirosePublished in: Diabetes, obesity & metabolism (2023)
In Japanese patients with early-stage type 2 diabetes, sitagliptin was associated with improved TIR in patients with a lower BMI. Dapagliflozin was effective in patients with a higher BMI. This article is protected by copyright. All rights reserved.